Express-Pick Library (Premium Version)

目录号 L5000

A unique collection of 111430 innovative compounds features numerous structurally diverse compounds and several alternate compositions.

サイズ 価格(税別)  
予めDMSOに溶解しています
ご連絡ください

Express-Pick Library (Premium Version)内容

If you need to download the Express-Pick Library (Premium Version)Contents (.xlsx and .sdf), please contact us via [email protected] about us.

製品特性＆メリット

・多様な構造をもっている、11430種類の化合物ライブラリーです。

・ファイザー社からライセンスを受け革新的な化合物を提供します。

・標的分子との相互作用をプローブする複雑な化学構造およびファーマコフォアは、新薬の発見速度を劇的に増加させます。

・NMRとHPLC検査で製品の高純度を保証しています。

製品詳細情報

調合： 111430種類のユニークな化合物はDMSO溶液に予め溶解された状態で提供されます。
96well： 96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
安定性： in DMSO
in DMSO
出荷方式： ブルーアイス物流
包装： 不活性ガス（Inert gas）

HTS パートナ

他のライブラリー

  • FDA-approved Drug Library

    A unique collection of 1890 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS).

  • Clinical Compound Library

    A unique collection of 603 clinical compounds for high throughput screening (HTS) and high content screening (HCS).

  • Bioactive Compound Library-I

    A unique collection of 4560 bioactive chemical compounds for high throughput screening (HTS) and high content screening (HCS).

  • Bioactive Compound Library-Ⅱ（Provided by Pfizer）

    A unique collection of 2863 bioactive chemical compounds（From Pfizer） for high throughput screening (HTS) and high content screening (HCS).

  • Kinase Inhibitor Library

    A unique collection of 599 kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).

  • Express-Pick Library (Provided by Pfizer)

    A unique collection of 4208 chemical compounds featured different core structures and structural diversities respectively for high throughput screening (HTS) and high content screening (HCS).

  • Natural Product Library

    A unique collection of 1605 natural products for high throughput screening (HTS) and high content screening (HCS).

  • Metabolism Compound Library

    A unique collection of 492 small molecules with biological activity in numerous metabolic pathway: glycometabolism, lipid metabolism, proteolysis, etc.

  • Target Selective Inhibitor Library

    A unique collection of 641 validated bioactive compounds covering over 603 targets.

  • Epigenetics Compound Library

    Selleck Epigenetic inhibitor Library contains various small molecule modulators (inhibitors and activators) with biological activity used for epigenetic research and associated assays.

  • Stem Cell Signaling Compound Library

    Selleck Stem Cell Small Molecule Compound Library contains various small molecule inhibitors with biological activity used for stem cell regulatory and signaling pathway research.

  • Inhibitor Library

    A unique collection of 2134 inhibitors for high throughput screening (HTS) and high content screening (HCS).

  • Apoptosis Compound Library

    A unique collection of 133 small molecules used for apoptosis research targeting Bcl-2,Caspase,p53,TNF-alpha,Mdm2,survivin, etc.

  • FDA-approved Drug Library(Simplified Edition)

    A unique collection of 1794 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS)

  • GPCR Compound Library

    Selleck GPCR Small Molecule Compound Library contains various small molecules targeting G protein coupled receptors with biological activity.

  • Cambridge Cancer Compound Library

    A unique collection of 230 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS).

  • Immunology/Inflammation Compound Library

    A unique collection of 400 small molecules modulators (inhibitors and activators) with biological activity used for Immunology/Inflammation research and associated assays.

  • Drug Repurposing Library

    A unique collection of 2262 drugs that are marketed around the world or that have passed phase 1 clinical trials for high throughput screening (HTS) and high content screening (HCS).

  • Pfizer Licensed Compound Library

    Selleck and Pfizer are proud to present a unique collection of 77 drug compounds licensed by Pfizer.

  • MAPK Inhibitor Library

    A unique collection of 73 small molecule inhibitors used for MAPK signaling research.

  • Fragment Library

    A unique collection of 939 Fragment compounds for Fragment-Based Drug Discovery (FBDD).

  • Neuronal Signaling Compound Library

    A unique collection of 672 small molecule compounds with biological activity used for neurologic research and associated assays

  • PI3K/Akt Inhibitor Library

    A unique collection of 135 small molecule inhibitors used for PI3K/Akt/mTOR pathway research.

  • Anti-diabetic Compound Library

    A unique collection of 47 small molecules affecting the development of diabetes.

  • Anti-infection Compound Library

    A unique collection of 465 anti-infective small molecules with biological activity of antibiotics,antifungal drugs,anti-HIV,etc.

  • Anti-cancer Compound Library

    A unique collection of 1118 anti-cancer small molecules for 12 types of cancers: Breast Cancer, Leukemia, Lung Cancer, Lymphoma, etc.

  • Tyrosine Kinase Inhibitor Library

    Tyrosine Kinase Inhibitor library is ideal database for high-throughput screening (HTS) and cell based high-content screening (HCS).

  • Ion Channel Ligand Library

    A unique collection of 114 small molecule modulators used for Ion channel research.

  • Protease Inhibitor Library

    A unique collection of 72 small molecule inhibitors used for chemical genomics, high-throughput screening (HTS), and high content screening (HCS).

  • Autophagy Compound Library

    A unique collection of 180 small molecules with autophagy-inducing or autophagy-inhibiting activity.

  • Bioactive Compound Library(Simplified Edition)

    A unique collection of 4339 bioactive chemical compounds for high throughput screening (HTS) and high content screening (HCS)

×

春節（旧正月）休暇に伴う納期遅延のお知らせ
上海工場が春節休業となるため、輸入が必要な製品の納期が通常より2週間ほど遅れます。
1月25日までにご注文いただきました製品は通常通り出荷させていただきます。1月28日-2月8日にご注文いただいた製品は２月19日以降の出荷となります。ご不便をおかけいたしますが、何卒ご理解くださいますようお願い申し上げます。